Approval · Notice of Compliance 37977 · 2026
ESTROGEL: Notice of Compliance 37977
Issued July 23, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37977
- Date
- July 23, 2026
- Company
- Organon Canada Inc.Kirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph with new safety and efficacy information. Product Monograph reformatted to the Master Template. Update to Patient Medication Information. Update to package insert
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ESTROGEL | Not yet assigned | — |
Medicinal ingredients
- ESTRADIOL HEMIHYDRATE 0.06 PER